KalVista Pharmaceuticals Aktie
13,30
EUR
-0,10
EUR
-0,75
%
15,67
USD
-0,38
USD
-2,37
%
Werbung
KalVista Pharmaceuticals Aktie Analyse
| 20.03.19 | KalVista Pharmaceuticals Buy | Needham & Company, LLC | |
| 21.09.18 | KalVista Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 31.08.17 | KalVista Pharmaceuticals Buy | BTIG Research |
Werbung
Werbung